Results 321 to 330 of about 5,474,071 (364)

Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone

open access: yesAdvanced Healthcare Materials, EarlyView.
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li   +9 more
wiley   +1 more source

How to add baskets to an ongoing basket trial with information borrowing. [PDF]

open access: yesStat Methods Med Res
Daniells L   +4 more
europepmc   +1 more source

Regulation of Stemness by NR1D2 in Colorectal Cancer. [PDF]

open access: yesBiomedicines
Alonso-García S   +10 more
europepmc   +1 more source

Futility Monitoring in Clinical Trials. [PDF]

open access: yesStat Med
Ortega-Villa AM   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy